COMMUNIQUÉS West-GlobeNewswire

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

16/10/2017 - 09:00

FIT Biotech Oy Company release October 16, 2017 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]

Solon Eiendom ASA : Primary insider notification

16/10/2017 - 08:30

(Oslo, Norway, 13 October 2017) Solon Eiendom ASA Board Member Tore Aksel Voldberg (through his wholly owned company Skøien AS) has today bought 20 000 shares in Solon Eiendom ASA at a price of NOK 18,7858. Following [...]

CleanSpace Demonstrates Third Generation Respirator Innovation at A+A International Trade Fair

16/10/2017 - 08:01

New, state of the art respirator technology provides smart connectivity and user personalization DUSSELDORF, Germany, Oct. 16, 2017 (GLOBE NEWSWIRE) -- CleanSpace Technology will be introducing their new light-weight, [...]

Nexstim Plc is negotiating an assembly and distribution arrangement in China and a financing arrangement for the financing of its bring-to-market strategy in Europe and the US

16/10/2017 - 08:00

Company announcement, Helsinki, 16 October 2017, at 9:00 am Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or " Company "), a medical technology company developing and marketing pioneering navigated non-invasive brain [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

16/10/2017 - 07:05

REGULATED INFORMATION GHENT, Belgium, 16 October 2017 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

Probiodrug initiates Phase 2b core program of PQ912 and details further strategy

16/10/2017 - 07:00

Probiodrug initiates Phase 2b core program of PQ912 and details further strategy Company moves seamlessly from finalization of the SAPHIR Phase 2a to next clinical stage Probiodrug takes a double-pronged strategy - [...]

ABLYNX ESTABLISHES SUBSIDIARY IN THE USA AND APPOINTS A GENERAL MANAGER

16/10/2017 - 07:00

GHENT, Belgium, 16 October 2017 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced the establishment of Ablynx, Inc., its subsidiary in the USA, and the appointment of Mr Daniel Schneider as the General [...]

INNATE PHARMA : IPH4102: Final results of the dose-escalation part of the Phase I study

16/10/2017 - 07:00

Final results of the dose-escalation part from the Phase I trial evaluating IPH4102 in patients with advanced cutaneous T-cell lymphomas presented at the EORTC CLTF meeting Marseille, France, October 16, 2017, 7:00 AM [...]

INNATE PHARMA : IPH4102: Résultats finaux de la partie escalade de dose de l'étude de Phase I

16/10/2017 - 07:00

Présentation des Résultats finaux de l'escalade de dose de l'essai de Phase I évaluant IPH4102 chez des patients atteints de lymphomes T cutanés avancés au congrès de l'EORTC CLTF Marseille, le 16 octobre 2017, 7h00 [...]

World Conference on Lung Cancer Sunday Press Conference: Introducing New Awards and Global Guidelines

15/10/2017 - 09:47

YOKOHAMA, Japan, Oct. 15, 2017 (GLOBE NEWSWIRE) -- The first press briefing at the International Association for the Study of Lung Cancer (IASLC) 18 th World Conference on Lung Cancer (WCLC) highlighted new awards and [...]

MITHRA ANNOUNCES COMPLETION OF RECRUITMENT IN DONESTA® PHASE II STUDY

13/10/2017 - 23:00

PRESS RELEASE MIThRA ANNOUNCES completion of recruitment in donesta® PhAse II study Donesta ® Phase II study remains on track to report top line data late Q1 2018 260 women recruited in total, of which 86 have already [...]

Medtronic and Mercy Announce Data Sharing Partnership to Accelerate Medical Device Innovation

13/10/2017 - 16:00

Real-World Clinical Data is Key to Creating More Effective Medical Devices and Enabling Better Patient Health DUBLIN and ST. LOUIS - October 13, 2017 - Medtronic plc (NYSE: MDT), the global leader in medical technology [...]

Novavax Announces Leadership Change

13/10/2017 - 13:30

GAITHERSBURG, Md., Oct. 13, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) announced today that Barclay A. "Buck" Phillips has submitted his resignation as Senior Vice President, Chief Financial Officer (CFO) and [...]

Inivata Collaborates with Genomics England to Assess Samples and Explore Potential of Liquid Biopsy to Improve Cancer Management and Patient Outcomes

13/10/2017 - 13:30

Inivata Collaborates with Genomics England to Assess Samples and Explore Potential of Liquid Biopsy to Improve Cancer Management and Patient Outcomes Pilot study to test Genomics England samples using Inivata's InVision [...]

Summit Therapeutics plc : Holding(s) in Company

13/10/2017 - 10:10

TR-1: S tandard form for notification of major holdings 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii : Summit Therapeutics PLC Sedol BN40HZ0 1b. Please [...]

AroCell AB: announces that a distribution agreement has been signed with Pathway Diagnostics Ltd, for distribution of the AroCell TK 210 ELISA test in United Kingdom and Ireland.

13/10/2017 - 08:50

"We very much look forward to this new collaboration with the England based Pathway Diagnostics for the distribution of our TK 210 ELISA test", states Jan Stålemark, AroCell CEO. "Pathway Diagnostics Ltd is a leading [...]

Solon Eiendom ASA : Primary insider notification

13/10/2017 - 08:30

(Oslo, Norway, 12 October 2017) Solon Eiendom ASA Board Member Tore Aksel Voldberg (through his wholly owned company Skøien AS) has today bought 35 000 shares in Solon Eiendom ASA at a price of NOK 18,4133. Following [...]

Nouveau logo, nouvelle charte, Medasys adopte une nouvelle identité visuelle

13/10/2017 - 08:30

Moderne et épurée, cette nouvelle charte, présentée dès le 13 octobre lors des JFR reflète pleinement la volonté du leader français d'intégration de SIH d'apporter une dimension dynamique et technologique à son identité [...]

Shire plc : New Formulation of ONCASPAR® (pegaspargase) Receives Positive CHMP Opinion in Europe for Patients with Acute Lymphoblastic Leukemia (ALL)

13/10/2017 - 08:04

New Formulation of ONCASPAR ® (pegaspargase) Receives Positive CHMP Opinion in Europe for Patients with Acute Lymphoblastic Leukemia (ALL) If approved, lyophilized formulation would offer three times longer shelf life [...]